AXSM
Axsome Therapeutics Inc
NASDAQ: AXSM · HEALTHCARE · BIOTECHNOLOGY
$183.95
-0.57% today
Updated 2026-04-29
Market cap
$9.46B
P/E ratio
—
P/S ratio
14.82x
EPS (TTM)
$-3.68
Dividend yield
—
52W range
$96 – $193
Volume
0.6M
Axsome Therapeutics Inc (AXSM) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
+4.8%
Last 4 quarters
Revenue YoY growth
+65.0%
Most recent quarter
EPS YoY growth
+63.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-7.5%
2026-02-23
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-23 | $-0.56 | +22.8% | $183.72 | $169.95 | -7.5% |
| 2025-11-03 | $-0.95 | -11.8% | $134.99 | $134.93 | -0.0% |
| 2025-08-04 | $-0.97 | +8.5% | $103.02 | $103.59 | +0.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.73 | $-0.56 | +22.8% | $196.00M | +65.0% |
| 2025-09-30 | $-0.85 | $-0.95 | -11.8% | $170.99M | +63.2% |
| 2025-06-30 | $-1.06 | $-0.97 | +8.5% | $150.04M | +72.1% |
| 2025-03-31 | $-1.21 | $-1.22 | -0.5% | $121.46M | +62.0% |
| 2024-12-31 | $-1.00 | $-1.54 | -53.6% | $118.77M | +66.0% |
| 2024-09-30 | $-1.41 | $-1.34 | +4.8% | $104.76M | +81.3% |
| 2024-06-30 | $-1.33 | $-1.67 | -25.6% | $87.17M | +86.7% |
| 2024-03-31 | $-1.20 | $-1.44 | -20.0% | $75.00M | — |
| 2023-12-31 | $-1.17 | $-2.08 | -77.8% | $71.53M | — |
| 2023-09-30 | $-1.20 | $-1.32 | -10.0% | $57.79M | — |
| 2023-06-30 | $-1.22 | $-1.54 | -26.2% | $46.70M | — |
Frequently asked questions
Has Axsome Therapeutics Inc beaten earnings estimates?
Axsome Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of +4.8% over the last 4 quarters.
How does AXSM stock react to earnings?
AXSM stock has moved an average of -2.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Axsome Therapeutics Inc's revenue growth rate?
Axsome Therapeutics Inc reported year-over-year revenue growth of +65.0% in its most recent quarter, with EPS growing +63.6% year-over-year.